Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. The company is headquartered in Basel, Basel-Stadt and currently employs 11,821 full-time employees. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
根据最新的财务报表(Form-10K),Straumann Holding AG 的总资产为 $0,净損失为 $0
SAUHY 的关键财务比率是什么?
Straumann Holding AG 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Straumann Holding AG 的收入按细分市场或地理位置如何划分?
Straumann Holding AG の最大収益セグメントは Implant Solutions で、最新の利益発表における収益は 1,529,280,000 です。地域別に見ると、Europe, Middle East & Africa が Straumann Holding AG の主要市場であり、収益は 1,067,969,000 です。